Our body's own defense system not only clears away bacteria and viruses, it can also fight cancer. However, not all tumor ...

Scientists have discovered a new immunotherapy strategy that reduces cancer recurrence in mouse experimental models. The study, published in Nature Communications, shows that a specific subtype of ...

Now, technological advances like rapid DNA sequencing, lymph node targeting, and AI-informed antigen ... cancer shows that Elicio’s vaccine induced 100-fold increases in tumor-specific T cells ...

IBI3014 is a bispecific ADC targeting TROP2 and PD-L1. Its dual mechanism integrates TROP2-directed tumor killing with PD-L1 ...

The new test looks for a specific type ... up about half of all skin cancer sufferers -- determined that approximately 80% of those who had evidence of circulating tumor DNA, or ctDNA, in their ...

SAN FRANCISCO and SUZHOU, China, April 28, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

A multi-institutional team developed a chimeric antigen receptor ... drugs are designed to target tumor-specific antigens, which are molecules only expressed by cancer cells.

Immunocore reports first quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $93.9 million in Q1 2025, growing by 33% year-over-year ...